Brief: Moberg Pharma Receives Favorable Outcome From NAD

Moberg Pharma AB (publ)

15/01/2018 07:34

Jan 15 (Reuters) - Moberg Pharma Ab (Publ)  MBPH.ST : 
    * MOBERG PHARMA RECEIVES FAVORABLE OUTCOME FROM NAD - MAIN 
COMPETITOR TO DISCONTINUE CURRENT MARKETING 
    * EXPECTS OUTCOME TO FURTHER STRENGTHEN KERASAL NAILS 
POSITION 
AND GROWTH PROSPECTS IN U.S. MARKET 
 
Source text for Eikon:  ID:nWkrfqqbY  
Further company coverage:  MBPH.ST  
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 587720920;))